| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8785344 | Brachytherapy | 2018 | 8 Pages |
Abstract
For elderly early breast cancer, a post-operative multi-catheter interstitial high-dose rate brachytherapy single dose (16 Gy) appears feasible. Acute toxicity is acceptable as well as early cosmetic outcome. Oncologic outcome seems encouraging and allows going forward with new clinical trials focusing on single fraction APBI.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Jean-Michel Hannoun-Lévi, Daniel Lam Cham Kee, Jocelyn Gal, Renaud Schiappa, Arthur Hannoun, Mathieu Gautier, Rabia Boulahssass, Isabelle Peyrottes, Emmanuel Barranger, Jean-Marc Ferrero, Marie-Eve Chand, Jérôme Doyen,